Home LiteratureArticle Details
PMID: 22745048 Published · ppublish English Case Reports Journal Article

Metronomic therapy for malignant peripheral nerve sheath tumor in neurofibromatosis type 1.

Pediatric blood & cancer ·Vol. 59 ·No. 7 ·2012-12-15 ·页码 1317-9

Chaudhary N, Borker A

Abstract

Malignant peripheral nerve sheath tumor (MPNST) is a highly aggressive tumor especially in the patients with neurofibromatosis type 1 (NF1). Without a complete surgical excision, prognosis is guarded. We describe a 10-year-old male with NF1 with MPNST, who had a local relapse within 5 weeks of surgical excision. Chemoradiotherapy did not result in tumor regression. Initiation of palliative oral metronomic therapy resulted in complete remission after six cycles. The patient continues to be in remission, 20 months after completion of nine cycles of metronomic therapy. Metronomic therapy may be effective in MPNST where conventional chemotherapy and radiotherapy fails.

MeSH 主题词
Administration, Metronomic Administration, Oral Antineoplastic Combined Chemotherapy Protocols/administration & dosage Child Humans Male Neoplasm Recurrence, Local Nerve Sheath Neoplasms/complications,drug therapy,surgery Neurofibromatosis 1/complications Palliative Care
作者与单位
共 2 位作者,点击展开单位 / ORCID
Chaudhary Narendra
Pediatric Hematology Oncology Unit, Department of Pediatrics, Kasturba Medical College, Manipal University, Manipal, Karnataka, India.
Borker Anupama
Article Info
Journal
Pediatric blood & cancer
Abbr.
Pediatr Blood Cancer
ISSN
1545-5017
Published
2012-12-15
电子出版
2012-00-28
页码
1317-9
Language
English
Country/Region
United States
NLM ID
101186624
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com